Treatment With Liraglutide Exerts Neuroprotection After Hypoxic–Ischemic Brain Injury in Neonatal Rats via the PI3K/AKT/GSK3β Pathway

Neonatal hypoxic–ischemic (HI) brain injury is a detrimental disease, which results in high mortality and long-term neurological deficits. Nevertheless, the treatment options for this disease are limited. Thus, the aim of the present study was to assess the role of liraglutide in neonatal HI brain i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Shan-shan, Bai, Jun-jie, Jiang, Huai, Zhu, Jin-jin, Fu, Chang-chang, He, Min-zhi, Zhu, Jiang-hu, Chen, Shang-qin, Li, Pei-jun, Fu, Xiao-qin, Lin, Zhen-lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003644/
https://www.ncbi.nlm.nih.gov/pubmed/32082121
http://dx.doi.org/10.3389/fncel.2019.00585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003644/
https://www.ncbi.nlm.nih.gov/pubmed/32082121
http://dx.doi.org/10.3389/fncel.2019.00585

Ejemplares similares